Form 4 for EDSA Edesa Biotech, Inc.
Accepted 2024-03-25 00:00:00 ET · period of report 2024-03-25 · accession 0001654954-24-003606 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-03-25 | 2024-03-25 | EDSA | Nijhawan Pardeep | CEO, Dir, 10% | P - Purchase | $4.00 | +5,000 | 341.7K | +1% | +$20.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2024-03-25 | P | A | 5,000 | $4.00 | 341,702 | I Held by Pardeep Nijhawan Medicine Professional Corporation | — | — | (F1) Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. |